Audit performed by the Royal College of Surgeons in England, 1996.
2.
Chang-ChienCSWuCSChenPC. Different implications of stigmata of recent haemorrhage in gastric and duodenal ulcers. Dig Dis Sci1988; 33:400–4.
3.
KubbaAKPalmerKR. Role of endoscopic injection therapy in the treatment of bleeding peptic ulcer. Br J Surg1996; 83:461–8.
4.
BramleyPNMassonJWalsheD. The impact of a specialized bleeding unit serving Grampian region: the way forward?Gut1993; 34(Suppl):F236.
5.
DaneshmendTKHawkeyCJLangmanMJLogan. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ1992; 304:143–7.
6.
ChungSSLauJYSungJJ. Randomised comparison between adrenalin injection alone and adrenalin injection plus heat probe treatment for actively bleeding ulcers. BMJ1997; 314:1307–11.
7.
BornmanPCTheodorouNAShuttleworthRD. Importance of hypovolaemic shock and endoscopic signs in predicting recurrent haemorrhage from peptic ulceration: a prospective evaluation. BMJ1985; 291:245–7.
8.
ClasonAEMacLeodDADEltonRA. Clinical factors in the prediction of mortality in acute upper gastrointestinal haemorrhage. Br J Surg1986; 73:985–7.
9.
JefferyKJReadSJPetoTE. Diagnosis of viral infections of the central nervous system: clinical interpretation of PCR results. Lancet1997; 349:313–7.
10.
ReadSRJeffreyKJMBanghamCRM. Aseptic meningitis and encephalitis: the role of PCR in the diagnostic laboratory. J Clin Microbiol1997; 35(3):691–6.
11.
WyliePAStevensDDrakeW. Epidemiology and clinical management of meningococcal disease in West Gloucestershire: retrospective, population based study. BMJ1997; 315:774–9.
12.
McIntyrePBBerkeyCSKingSM. Dexamethazone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomised clinical trials since 1988. JAMA1997; 178:925–31.
13.
SaettaJPQuintonDN. Residual gastric content after gastric lavage and ipecacuanha-induced emesis in self-poisoned patients: an endoscopic study. J R Soc Med1991; 84(1):35–8.
14.
PrescottLFParkJBallantyneA. Treatment of paracetamol (acetaminophen) poisoning with N acetylcysteine. Lancet1977; 2:432–4.
15.
LheureuxPVranckxMLeducDAskenasiR. Risks of flumazenil in mixed benzodiazepine-tricyclic antidepressant overdose: report of a preliminary study in the dog. J Toxicol Clin Exp1992; 12(1):43–53.
16.
PrescottLFRoscoePWrightNBrownSS. Plasma paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet1971; 1:519–22.
17.
GunnellDFrankelS. Prevention of suicide: aspirations and evidence. BMJ1994; 308:1227–33.
18.
Royal College of Psychiatrists. Guidelines on the management of DSH.
19.
LinnFHWijdicksEFvan der GraafY. Prospective study of sentinel headache in aneurysmal subarachnoid haemorrhage. Lancet1994; 344:590–3.
20.
GREAT Group. Feasability, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. BMJ1992; 305:548–53.
21.
SrikanthanVSPellACPrasadN. Use of fax facility improves decision making regarding thrombolysis in acute myocardial infarction. Heart1997; 78(2):198–200.
22.
ChauhanAPetchMCSchoffieldPM. Cardio-oesophageal reflex in humans as a mechanism for ‘linked angina’. Eur Heart J1996; 17(3):407–13.
23.
DaviesMJThomasMJ. Plaque fissuring: the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J1985; 53:363–73.
24.
BertrandMEBraunwaldEDaviesMJ. Confronting the challenge of acute coronary syndromes. Clin Card1997; 20(suppl 1):1–26.
25.
LibbyP. Molecular basis of the acute coronary syndromes. Circulation1995; 91:2844–50.
26.
Anon. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study. Lancet1997; 349:1429–35.
27.
CaliffRMLincoffAMTchengJETopolEJ. An overview of the results of the EPIC trial. Eur Heart J1995; 16(Suppl L):43–49.
28.
de WerfF. More evidence for beneficial effect of platelet glycoprotein IIb/IIIa-blockade during coronary interventions. Latest results from the EPILOG and CAPTURE trials. Eur Heart J1996; 17(3):325–6.
29.
The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis. Circulation1997; 96(5):1445–53.
30.
Anon. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II. Lancet1997; 349(9063):1422–8.
31.
HarringtonRA. Design and methodology of the PURSUIT trial: evaluating eptifibatide for acute ischaemic coronary syndromes. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. Am J Cardiol1997; 80(4A):34B-38B.
32.
CohenMAdamsPCParryG. Combination antithrombotic therapy in unstable rest angina and non Q wave infarction in non prior aspirin users, primary end points analysis from the ATACS trial Antithrombotic Therapy in Acute Coronary Syndromes Research Group. Circulation1994; 89:81–8.
33.
SwahnEWallentinL. Low-molecular-weight heparin (Fragmin) during instability in coronary artery disease (FRISC). FRISC Study Group. Am J Cardiol1997; 80(5A):25E-29E.
34.
BovillEGTracyRPKnattgrudGL. Haemorrhagic events during therapy with recombinant tissue plasminogen activator, heparin, and aspirin for unstable angina (thrombolysis in myocardial ischaemia, phase IIIb trial). Am J Cardiol1997; 79:391–6.
35.
The antiarrhythmics versus implantable defibrillators (AVID) investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med1997; 337:1576–83